Voraxaze

Active Ingredient(s): Glucarpidase
FDA Approved: * January 17, 2012
Pharm Company: * BTG INTERNATIONAL INC
Category: Antidotes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Voraxaze Overview

A carboxypeptidase (EC number 3.4.16 - 3.4.18) is a protease enzyme that hydrolyzes (cleaves) a peptide bond at the carboxy-terminal (C-terminal) end of a protein or peptide. This is in contrast to a aminopeptidases, which cleave peptide bonds at the N-terminus of proteins. Humans, animals, bacteria and plants contain several types of carboxypeptidases that have diverse functions ranging from catabolism to protein maturation. Contents 1 Mechanism 2 Functions 3 Classifications 3.1 By acti...

Read more Voraxaze Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carboxypeptidase

Recent Voraxaze Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glucarpidase
  • Injection: 1000 units per vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Voraxaze: (1 result)

Sorted by National Drug Code
  • 50633-210 Voraxaze 1000 [usp'u]/1 Intravenous Injection, Powder, for Solution by Btg International Inc.

Other drugs which contain Glucarpidase or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA